Publish in this journal
Journal Information
Vol. 13. Issue 5.
Pages 252-257 (September - October 2017)
Share
Share
Download PDF
More article options
ePub
Visits
...
Vol. 13. Issue 5.
Pages 252-257 (September - October 2017)
Original Article
DOI: 10.1016/j.reumae.2016.05.011
Profile of Patients With Fibromyalgia Being Treated in Primary Care Centers in Terrassa, a City in Northeastern Spain
Perfil de pacientes con fibromialgia que acuden a los centros de atención primaria en Terrassa
Visits
...
Teresa Mur Martía,
Corresponding author
, Montse Llordés Llordésb, Mercè Custal Jordàc, Gemma López Juand, Silvia Martínez Pardoe
a Medicina de Familia, Centro Atención Primaria Rubí 1, Mútua Terrassa, Rubí, Barcelona, Spain
b Medicina de Familia, Centro Atención Primaria Terrassa Sud, Mútua Terrassa, Terrassa, Barcelona, Spain
c Medicina de Familia, Centro Atención Primaria Rambla, Mútua Terrassa, Terrassa, Barcelona, Spain
d Medicina Familiar y Comunitaria, CAP Terrassa Sud, Mútua Terrassa, Terrassa, Barcelona, Spain
e Servicio Reumatología, Hospital Universitari Mútua Terrassa, Terrassa, Barcelona, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (4)
Table 1. Sociodemographic Data on the Population With Fibromyalgia.
Table 2. Associated Diseases and Data on Fibromyalgia.
Table 3. Consumption of Drugs Prescribed for Fibromyalgia.
Table 4. Fibromyalgia Impact Questionnaire (FIQ), Family Dysfunction (APGAR) and Associated Psychiatric Disorders (HADS).
Show moreShow less
Abstract
Objective

To perform an extensive clinical and epidemiological characterization of our fibromyalgia patients.

Patients, material, and method

Two-year observational study in 3 primary care centers in Terrassa, Spain. We recruited a sample of 235 individuals diagnosed with fibromyalgia being treated in primary care or rheumatology clinics who, when offered inclusion in a multidisciplinary program, agreed to provide the initial data we requested. The main measures were sociodemographic data, unhealthy habits and physical activity, comorbidities, treatment for fibromyalgia, Fibromyalgia Impact Questionnaire (FIQ), Hospital Anxiety and Depression Scale (HADS), and a family functioning scale (family APGAR).

Main results

In all, 97.8% were women and the average age was 54.6 years. Most of the patients had a primary school education and the majority was on sick leave. Ninety-four percent had associated comorbidity and only 3% were not taking any medication for their disease. Many were taking drugs with no proven efficacy in fibromyalgia. The majority had intermediate scores on the FIQ, the HADS showed that 63% and 53% had an anxious and/or probable depressive disorder, respectively, and, according to the family APGAR score, 62% received proper family support.

Conclusions

In agreement with the literature, the major findings in our fibromyalgia patients were a marked predominance of women, a high incidence of comorbidities—mainly psychiatric disorders—a moderate impact of the disease and widespread use of drugs with no demonstrated efficacy.

Keywords:
Fibromyalgia
Primary care
Comorbidity
Resumen
Objetivo

Realizar una amplia caracterización clínica y epidemiológica de nuestra población afectada de fibromialgia.

Pacientes, material y método

Estudio observacional a lo largo de 2años realizado en 3 centros de atención primaria de Terrassa. Muestra de 235 personas diagnosticadas de fibromialgia visitadas en consultas de atención primaria o de reumatología a las que se ofrece la asistencia al programa multidisciplinar y aceptan completar los datos iniciales del programa. Las mediciones principales fueron: datos sociodemográficos; hábitos tóxicos y ejercicio físico; comorbilidades; tratamientos para la fibromialgia; cuestionario de impacto de la fibromialgia (FIQ); escala hospitalaria de ansiedad-depresión (HADS), y cuestionario de funcionalidad familiar (APGAR familiar).

Principales resultados

El 97,8% son mujeres; edad media, 54,6años. Predominio de pacientes con estudios primarios y en situación de baja laboral. El 94% tienen comorbilidad asociada y solo el 3% no consumen ningún fármaco para su patología, a la vez que hay un elevado consumo de fármacos sin evidencia de efectividad en la fibromialgia. La mayoría puntúan como nivel moderado en el cuestionario de Impacto de la fibromialgia (FIQ); tienen patología ansiosa y/o depresiva probable en el 63 y el 53%, respectivamente, según la Escala hospitalaria de ansiedad y depresión (HADS) y soporte familiar correcto en el 62%, según el test APGAR familiar.

Conclusiones

Se confirman como datos principales y coincidiendo con la bibliografía la gran prevalencia de la fibromialgia en mujeres, con elevada comorbilidad especialmente psiquiátrica-psicológica, con moderado impacto de la enfermedad y con importante consumo de fármacos sin eficacia demostrada.

Palabras clave:
Fibromialgia
Atención primaria
Comorbilidad

Article

These are the options to access the full texts of the publication Reumatología Clínica (English Edition)
Member
If you are member of Sociedad Española de Reumatología (SER) or the Colegio Mexicano de Reumatología (CMR):
Please go to the member area of SER or CMR and log in.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Reumatología Clínica (English Edition)

Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 22,50 €

Comprar ahora
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.